Terms: = Colorectal cancer AND Beta-hCG AND Diagnosis
7 results:
1. A rare case of primary rectal choriocarcinoma and review of the literature.
Telli TA; Demircan NC; Alan O; Tuylu TB; Arikan R; Ercelep O; Atıcı AE; Ergelen R; Seven IE; Babacan NA; Kaya S; Dane F; Fulden Yumuk P
J Oncol Pharm Pract; 2020 Jun; 26(4):989-994. PubMed ID: 31547751
[TBL] [Abstract] [Full Text] [Related]
2. Discrepant serum and urine β-hCG results due to production of β-hCG by a cribriform-morular variant of thyroid papillary carcinoma.
Alikhan M; Koshy A; Hyjek E; Stenson K; Cohen RN; Yeo KT
Clin Chim Acta; 2015 Jan; 438():181-5. PubMed ID: 25181612
[TBL] [Abstract] [Full Text] [Related]
3. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement.
Chen C; Chen LQ; Yang GL; Li Y
J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164
[TBL] [Abstract] [Full Text] [Related]
4. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract] [Full Text] [Related]
5. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract] [Full Text] [Related]
6. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Canil CM; Tannock IF
Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
[TBL] [Abstract] [Full Text] [Related]
7. Adenocarcinoma of the colon with syncytiotrophoblastic differentiation: differential diagnosis and implications.
Metz KA; Richter HJ; Leder LD
Pathol Res Pract; 1985 Jan; 179(3):419-24. PubMed ID: 4039056
[TBL] [Abstract] [Full Text] [Related]
